Please login to the form below

Not currently logged in
Email:
Password:

LY-CoV555

This page shows the latest LY-CoV555 news and features for those working in and with pharma, biotech and healthcare.

Independent consultant will review Lilly’s COVID-19 plant issues

Independent consultant will review Lilly’s COVID-19 plant issues

The study had been evaluating Lilly’s investigational neutralising antibody bamlanivimab (LY-CoV555) as a treatment for COVID-19 in hospitalised patients, and is sponsored by the US National Institute of

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics